MedTrace Logo

Utilization of Musculoskeletal Ultrasound to Detect Subclinical Findings in IBD Patients

NCT07205549 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2025-10-03

No results posted yet for this study

Summary

Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, frequently presents with musculoskeletal extraintestinal manifestations (EIMs), such as arthritis and enthesitis, affecting up to 50% of patients. These can be subclinical and are often underestimated by physical examination alone. Musculoskeletal ultrasound (MSK-US) is a sensitive, non-invasive tool for detecting both clinical and subclinical inflammation. Despite its benefits, there is no standardized MSK-US protocol specifically for IBD patients. This study aims to develop a structured MSK-US assessment protocol, evaluate its effectiveness in detecting musculoskeletal involvement, and investigate its relationship with IBD disease activity.

Conditions

  • IBD (Inflammatory Bowel Disease)
  • Musculoskeletal Ultrasound

Interventions

RADIATION

MSK Ultrasound with Doppler on joints, muscles & tendons

Musculoskeletal Ultrasound (MSK-US) is a non-invasive, real-time, and sensitive imaging modality that can detect synovial hypertrophy, joint effusion, enthesitis, tenosynovitis, bursitis, and power Doppler (PD) signal indicative of active inflammation. Unlike standard clinical assessment, which may miss subclinical inflammation.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Wael A Abbas, MD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2025-11-30
Completion
2025-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07205549 on ClinicalTrials.gov